Literature DB >> 15631642

Neurologic aspects of infections in international travelers.

May H Han1, Joseph R Zunt.   

Abstract

BACKGROUND: As international travel for business and pleasure becomes part of contemporary lifestyle, the clinician today is confronted with an increasing number of travelers returning ill with unfamiliar syndromes. The physician will encounter a myriad of patients with exotic infections, emerging infectious diseases, or resurgent Old-World infections. REVIEW
SUMMARY: This review article will discuss salient points of important infectious diseases associated with overseas travel, provide a syndromic approach to the traveler who returns with neurologic manifestations, and list resources for additional diagnostic, therapeutic, and preventive information.
CONCLUSIONS: As many of infections acquired in other countries can directly or indirectly affect the nervous system, the care of the ill traveler often falls into the hands of neurologists. The contemporary neurologist should therefore be knowledgeable of the clinical manifestations, potential complications, and appropriate management of region-specific infections.

Entities:  

Mesh:

Year:  2005        PMID: 15631642      PMCID: PMC2678057          DOI: 10.1097/01.nrl.0000149972.87731.0f

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  116 in total

1.  [Development of Kozhevnikov's epilepsy in tick-borne encephalitis].

Authors:  A N Shapoval; M F Garishina
Journal:  Vrach Delo       Date:  1976-07

2.  Lassa fever: response to an imported case.

Authors:  R M Zweighaft; D W Fraser; M A Hattwick; W G Winkler; W C Jordan; M Alter; M Wolfe; H Wulff; K M Johnson
Journal:  N Engl J Med       Date:  1977-10-13       Impact factor: 91.245

3.  [Epidemiology of West Nile virus. Study of a center in Camargue. 3.-Human diseases].

Authors:  R Panthier; C Hannoun; D Beytout; J Mouchet
Journal:  Ann Inst Pasteur (Paris)       Date:  1968-09

4.  Neuro-psychiatric manifestations of typhoid.

Authors:  S N Khosla; S C Srivastava; S Gupta
Journal:  J Trop Med Hyg       Date:  1977-05

5.  MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease.

Authors:  Catalina Ionita; Mohammed Wasay; Lucia Balos; Rohit Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

6.  West Nile virus and "poliomyelitis".

Authors:  James J Sejvar
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

7.  A comparison of clinical and radiological findings in adults and children with Japanese encephalitis.

Authors:  J Kalita; U K Misra; S Pandey; T N Dhole
Journal:  Arch Neurol       Date:  2003-12

Review 8.  Changing paradigms in parasitic infections: common dermatological helminthic infections and cutaneous myiasis.

Authors:  Terri L Meinking; Craig N Burkhart; Craig G Burkhart
Journal:  Clin Dermatol       Date:  2003 Sep-Oct       Impact factor: 3.541

Review 9.  Tick-borne flaviviruses.

Authors:  T S Gritsun; P A Nuttall; Ernest A Gould
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

10.  Prevalence of viral infection markers by polymerase chain reaction amplification and interferon-alpha measurements among patients undergoing lumbar puncture in an emergency department.

Authors:  Pierre Hausfater; Anne-Marie Fillet; Flore Rozenberg; Martine Arthaud; David Trystram; Jean-Marie Huraux; Pierre Lebon; Bruno Riou
Journal:  J Med Virol       Date:  2004-05       Impact factor: 2.327

View more
  2 in total

Review 1.  An overview of travel-associated central nervous system infectious diseases: risk assessment, general considerations and future directions.

Authors:  Morteza Izadi; Arman Is'haqi; Mohammad Ali Is'haqi; Nematollah Jonaidi Jafari; Fatemeh Rahamaty; Abdolali Banki
Journal:  Asian Pac J Trop Biomed       Date:  2014-08

Review 2.  Neurologic parasitic infections in immigrants and travelers.

Authors:  Kiran Thakur; Joseph Zunt
Journal:  Semin Neurol       Date:  2011-09-30       Impact factor: 3.420

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.